Company: THRM
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0001140361-25-010582
Chunk: 92

Company: Gentherm Inc
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 92
---
5 PROXY STATEMENT

| – | the impact of global economic and trade policies, including increases in duties, tariffs and taxation on the import or export of our products related to U.S. trade disputes; |

| – | our ability to attract and retain highly skilled employees and wage inflation; |

| – | a tightening labor market, labor shortages or work stoppages impacting us, our customers or our suppliers, such as recent labor strikes among certain OEMs and suppliers; |

| – | our achievement of product cost reductions to offset customer-imposed price reductions or other pricing pressures; |

| – | our product quality and safety and impact of product safety recalls and alleged defects in products; |

| – | our ability to execute efforts to optimize our global supply chain and manufacturing footprint, including opening new facilities and transferring production; |

| – | our ability to integrate our recent acquisitions and realize synergies, as well as to consummate additional strategic acquisitions, investments and exits, and achieve planned benefits; |

| – | any security breaches and other disruptions to our information technology networks and systems, as well as privacy, data security and data protection risks, including risks associated with use of 
 artificial intelligence capabilities in our business operations;                                                                                                                                    |

| – | any loss or insolvency of our key customers and OEMs, or key suppliers; |

| – | our ability to project future sales volume based on third-party information, based on which we manage our business; |

| – | the protection of our intellectual property in certain jurisdictions; |

| – | our compliance with global anti-corruption laws and regulations; |

| – | legal and regulatory proceedings and claims involving us or one of our major customers; |

| – | the extensive regulation of our patient temperature management business; |

| – | risks associated with our manufacturing processes; |

| – | the effects of climate change and catastrophic events, as well as regulatory and stakeholder-imposed requirements to address climate change and other sustainability issues; |

| – | our product quality and safety; |

| – | our borrowing availability under our revolving credit facility, as well ability to access the capital markets, to support our planned growth; |

| – | our indebtedness and compliance with our debt covenants; and |

| – | other risks, uncertainties and other factors set forth in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K for 2023, and subsequent reports filed with or furnished to the U.S. 
 Securities and Exchange Commission.